Gurnet Point L.P. 13D/13G Filings for Eloxx Pharmaceuticals, Inc. (ELOX)

Gurnet Point L.P. 13D and 13G filings for Eloxx Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-06-29
09:13 am
Purchase
2021-05-1813GEloxx Pharmaceuticals, Inc.
ELOX
Gurnet Point L.P.124,418
5.700%
124,418increase
(New Position)
Filing